Current Drug Metabolism

Editor-in-Chief:

Michael Sinz

Bristol Myers Squibb

Princeton, NJ

USA

 

Back

Become EABM
Become Reviewer

Editorial [ Hot topic:Updates on Therapeutic Approaches to Inflammatory Skin Diseases: From Molecular Targets to Drug Development. Part I (Guest Editors: L. Korkina & S. Pastore) ] promotion: free to download

Volume:11   Issue:3
Pp: 208-209
L. Korkina and S. Pastore
DOI: 10.2174/138920010791196292

Allergic Contact Dermatitis: Novel Mechanisms and Therapeutic Perspectives

Volume:11   Issue:3
Pp: 228-233
Andrea Cavani and Anastasia De Luca
DOI: 10.2174/138920010791196300

Therapeutic Management of Atopic Eczema

Volume:11   Issue:3
Pp: 234-241
Claudia Traidl-Hoffmann, Martin Mempel, Benedetta Belloni, Johannes Ring and Christina Schnopp
DOI: 10.2174/138920010791196319

Skin Protection Against UVA-Induced Iron Damage by Multiantioxidants and Iron Chelating Drugs/Prodrugs

Volume:11   Issue:3
Pp: 242-249
Olivier Reelfs, Ian M. Eggleston and Charareh Pourzand
DOI: 10.2174/138920010791196265

HMGB1-Directed Drug Discovery Targeting Cutaneous Inflammatory Dysregulation

Volume:11   Issue:3
Pp: 250-265
Sarah D. Lamore, Christopher M. Cabello and Georg T. Wondrak
DOI: 10.2174/138920010791196337

NF-κB Signature on the Aging Wall

Volume:11   Issue:3
Pp: 266-275
Doaa Hussein Zineldeen, Hiroaki Uranishi and Takashi Okamoto
DOI: 10.2174/138920010791196283

How and Why to Screen for CYP2D6 Interindividual Variability in Patients Under Pharmacological Treatments

Volume:11   Issue:3
Pp: 276-282
Manuela De Gregori, Massimo Allegri, Simona De Gregori, Giulia Garbin, Carmine Tinelli, Mario Regazzi, Stefano Govoni and Guglielmina Nadia Ranzani
DOI: 10.2174/138920010791196274